We are live on
!
Find out more
Phoenix Financial Portfolio holdings
AUM
$14.6B
Turnover
27.99%
1-Year Est. Return
57.48%
This Fund
S&P 500
This Quarter
Est. Return
+12.68%
1 Year Est. Return
+57.48%
3 Year Est. Return
+144.13%
5 Year Est. Return
+130.73%
10 Year Est. Return
–
AUM
$2.39B
AUM Growth
+$282M
(+13%)
Cap. Flow
-$20.6M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
227
New
37
Increased
46
Reduced
80
Closed
31
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$29.2M |
| 2 |
DuPont de Nemours
DD
|
+$27.6M |
| 3 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$23.6M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$23.4M |
| 5 |
Corteva
CTVA
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNH Industrial
CNH
|
+$20.3M |
| 2 |
Viatris
VTRS
|
+$19.5M |
| 3 |
Conagra Brands
CAG
|
+$17.4M |
| 4 |
AGN
Allergan plc
AGN
|
+$14.8M |
| 5 |
The Mosaic Company
MOS
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 10.89% |
| 4 | Financials | 9.53% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $389K | 0.02% |
4,824
| – | – |
2019 Q3
1 quarter
|
|
|
RDS.B
177
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $387K | 0.02% |
6,500
| – | – |
2019 Q3
1 quarter
|
|
|
TUFN
178
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $354K | 0.01% |
+20,247
| New | +$346K |
2019 Q4
0 quarters
|
|
179
CEVA Inc
CEVA
$824M
| $340K | 0.01% |
12,684
-1,168
| -8% | -$31.9K |
2019 Q3
1 quarter
|
|
180
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $337K | 0.01% |
+11,014
| New | +$323K |
2019 Q4
0 quarters
|
|
181
Sunrun
RUN
$1.84B
| $307K | 0.01% |
+22,400
| New | +$334K |
2019 Q4
0 quarters
|
|
182
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $296K | 0.01% |
6,400
| – | – |
2019 Q3
1 quarter
|
|
183
InMode
INMD
$824M
| $287K | 0.01% |
+14,734
| New | +$277K |
2019 Q4
0 quarters
|
|
184
First Trust Cloud Computing ETF
SKYY
$3.38B
| $259K | 0.01% |
4,320
-32,830
| -88% | -$1.92M |
2019 Q3
1 quarter
|
|
185
Compugen
CGEN
$197M
| $255K | 0.01% |
43,086
-12,784
| -23% | -$65.8K |
2019 Q3
1 quarter
|
|
186
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.75B
| $252K | 0.01% |
7,180
| – | – |
2019 Q3
1 quarter
|
|
|
DSPG
187
DELISTED
DSP Group Inc
DSPG
| $240K | 0.01% |
15,352
-1,327
| -8% | -$19.5K |
2019 Q3
1 quarter
|
|
|
FOMX
188
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $180K | 0.01% |
54,502
-9,771
| -15% | -$31.1K |
2019 Q3
1 quarter
|
|
189
Ceragon Networks
CRNT
$184M
| $148K | 0.01% |
70,866
+6,858
| +11% | +$15.4K |
2019 Q3
1 quarter
|
|
|
GMDA
190
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $125K | 0.01% |
29,203
| – | – |
2019 Q3
1 quarter
|
|
191
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $124K | 0.01% |
1,938
-526
| -21% | -$30.5K |
2019 Q3
1 quarter
|
|
192
Opko Health
OPK
$1.2B
| $107K | ﹤0.01% |
73,000
| – | – |
2019 Q3
1 quarter
|
|
193
Eocene Ltd. Ordinary Shares
EOCN
$3.26M
| $105K | ﹤0.01% |
13
-5
| -28% | -$34.4K |
2019 Q3
1 quarter
|
|
194
Indaptus Therapeutics
INDP
$380M
| $72K | ﹤0.01% |
64
+49
| +327% | +$67.6K |
2019 Q3
1 quarter
|
|
|
CEL
195
DELISTED
Cellcom Israel, Ltd.
CEL
| $65K | ﹤0.01% |
20,840
-1,072,000
| -98% | -$2.91M |
2019 Q3
1 quarter
|
|
196
Chemomab Therapeutics
CMMB
$9.45M
| $36K | ﹤0.01% |
408
| – | – |
2019 Q3
1 quarter
|
|
197
ADMA Biologics
ADMA
$2.4B
| – | – |
-34,034
| Closed | -$144K | – |
|
198
Blackrock
BLK
$174B
| – | – |
-25,000
| Closed | -$10.6M | – |
|
199
BioLineRX
BLRX
$10.2M
| – | – |
-643
| Closed | -$65K | – |
|
200
CALL
Camtek
CAMT
$6.13B
| – | – |
-200,300
| Closed | -$1.88M | – |
|
Similar funds
Phoenix Financial's Q4 2019 Portfolio in Review
As of Q4 2019, Phoenix Financial held 227 positions worth $2.39B, up 13% from $2.11B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Phoenix Financial's Q4 2019 filing shows 37 new, 46 increased, 80 reduced and 31 closed positions. Its largest new stake was DuPont de Nemours: 332,409 shares worth $26.6M. The largest sale was CNH Industrial, an estimated $20.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Phoenix Financial's largest Q4 2019 buy was DuPont de Nemours: 332,409 shares worth $26.6M.
- Phoenix Financial added most to VanEck Gold Miners ETF in Q4 2019, an estimated $29.2M increase.
- Phoenix Financial's biggest Q4 2019 reduction was Viatris, cutting an estimated $19.5M.
- Phoenix Financial fully exited CNH Industrial in Q4 2019, selling an estimated $20.3M.
- Phoenix Financial's ten largest holdings make up 20% of its $2.39B portfolio in Q4 2019.
- Phoenix Financial opened 37 new positions and closed 31 in Q4 2019.
- Phoenix Financial's portfolio value rose 13% quarter-over-quarter to $2.39B.
Based on Phoenix Financial's 13F filing for Q4 2019, filed 18 Feb 2020.